191 related articles for article (PubMed ID: 12479587)
1. Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: effect on arachidonic acid uptake.
Salah-Uddin H; Gordon MJ; Ford I; Tandon NN; Greaves M; Duttaroy AK
Mol Cell Biochem; 2002 Oct; 239(1-2):203-11. PubMed ID: 12479587
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet CD36 constitutes a common marker in myeloproliferative disorders.
Thibert V; Bellucci S; Cristofari M; Gluckman E; Legrand C
Br J Haematol; 1995 Nov; 91(3):618-24. PubMed ID: 8555064
[TBL] [Abstract][Full Text] [Related]
3. A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes.
Pelsers MM; Lutgerink JT; Nieuwenhoven FA; Tandon NN; van der Vusse GJ; Arends JW; Hoogenboom HR; Glatz JF
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):407-14. PubMed ID: 9895283
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
5. Selective transport of long-chain fatty acids by FAT/CD36 in skeletal muscle of broilers.
Guo J; Shu G; Zhou L; Zhu X; Liao W; Wang S; Yang J; Zhou G; Xi Q; Gao P; Zhang Y; Zhang S; Yuan L; Jiang Q
Animal; 2013 Mar; 7(3):422-9. PubMed ID: 23031491
[TBL] [Abstract][Full Text] [Related]
6. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36.
Febbraio M; Guy E; Coburn C; Knapp FF; Beets AL; Abumrad NA; Silverstein RL
Mol Cell Biochem; 2002 Oct; 239(1-2):193-7. PubMed ID: 12479585
[TBL] [Abstract][Full Text] [Related]
7. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake.
Coort SL; Willems J; Coumans WA; van der Vusse GJ; Bonen A; Glatz JF; Luiken JJ
Mol Cell Biochem; 2002 Oct; 239(1-2):213-9. PubMed ID: 12479588
[TBL] [Abstract][Full Text] [Related]
8. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36.
Brinkmann JF; Abumrad NA; Ibrahimi A; van der Vusse GJ; Glatz JF
Biochem J; 2002 Nov; 367(Pt 3):561-70. PubMed ID: 12088505
[TBL] [Abstract][Full Text] [Related]
9. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.
Luiken JJ; Koonen DP; Willems J; Zorzano A; Becker C; Fischer Y; Tandon NN; Van Der Vusse GJ; Bonen A; Glatz JF
Diabetes; 2002 Oct; 51(10):3113-9. PubMed ID: 12351456
[TBL] [Abstract][Full Text] [Related]
10. Intestinal lipid absorption is not affected in CD36 deficient mice.
Goudriaan JR; Dahlmans VE; Febbraio M; Teusink B; Romijn JA; Havekes LM; Voshol PJ
Mol Cell Biochem; 2002 Oct; 239(1-2):199-202. PubMed ID: 12479586
[TBL] [Abstract][Full Text] [Related]
11. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
[TBL] [Abstract][Full Text] [Related]
13. Effect of bowel resection and high-fat diet on heart CD36/fatty-acid translocase expression in a rat model of short-bowel syndrome.
Sukhotnik I; May N; Gork AS; Chen M; Drongovski RA; Coran AG; Harmon CM
Pediatr Surg Int; 2002 Oct; 18(7):620-3. PubMed ID: 12471478
[TBL] [Abstract][Full Text] [Related]
14. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency.
Luiken JJ; Arumugam Y; Bell RC; Calles-Escandon J; Tandon NN; Glatz JF; Bonen A
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E612-21. PubMed ID: 12169456
[TBL] [Abstract][Full Text] [Related]
15. Regulation of fatty acid transport and membrane transporters in health and disease.
Bonen A; Luiken JJ; Glatz JF
Mol Cell Biochem; 2002 Oct; 239(1-2):181-92. PubMed ID: 12479584
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered.
Koonen DP; Benton CR; Arumugam Y; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E1042-9. PubMed ID: 15140757
[TBL] [Abstract][Full Text] [Related]
17. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.
Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E781-9. PubMed ID: 15166001
[TBL] [Abstract][Full Text] [Related]
18. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats.
Coort SL; Luiken JJ; van der Vusse GJ; Bonen A; Glatz JF
Biochem Soc Trans; 2004 Feb; 32(Pt 1):83-5. PubMed ID: 14748718
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide production and arachidonic acid metabolism in platelet membranes of coronary heart disease patients with and without diabetes.
Tretjakovs P; Kalnins U; Dabina I; Erglis A; Dinne I; Jurka A; Latkovskis G; Zvaigzne A; Pirags V
Med Princ Pract; 2003; 12(1):10-6. PubMed ID: 12566962
[TBL] [Abstract][Full Text] [Related]
20. Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.
Takahashi R; Morita I; Saito Y; Ito H; Murota S
Diabetologia; 1984 Feb; 26(2):134-7. PubMed ID: 6425101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
